Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

2 recruiting2 with results

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 2
1(25.0%)
4Total
N/A(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT03364660Not ApplicableRecruiting

Task-specific Epidural Stimulation Study

Role: collaborator

NCT02339233Not ApplicableCompleted

Epi Stim to Facilitate Standing and Stepping

Role: collaborator

NCT01597518Phase 2Terminated

Riluzole in Spinal Cord Injury Study

Role: collaborator

NCT00178724Recruiting

Spinal Cord Injury Registry - North American Clinical Trials Network

Role: collaborator

NCT00221117Not ApplicableCompleted

Benefits of Applying Neuroprosthesis to Improve Grasping and Reaching in Spinal Cord Injury Patients

Role: collaborator

NCT00876889Completed

Safety of Riluzole in Patients With Acute Spinal Cord Injury

Role: collaborator

All 6 trials loaded